Drug firm Ipca Laboratories today said its net profit dipped marginally to Rs 63.93 crore for the third quarter ended December 31, 2011, on account of forex losses due to rupee depreciation.
The company had posted a net profit of Rs 63.95 crore for the quarter ended December 31, 2010, Ipca Laboratories said in a filing to the Bombay Stock Exchange (BSE).
"The flat net profit is on account of forex transactions/translations losses of Rs 39.88 crore in Q3, FY12... On account of rupee depreciation," it added.
Total income of the company stood at Rs 614.83 crore for the quarter ended December 31, 2011, as against Rs 466.36 crore for the corresponding period last fiscal.
The company also said its board has declared a second interim dividend of Re 1 per share for the 2011-12 fiscal.
Shares of Ipca Laboratories settled at Rs 298.50 apiece on the BSE today, up 5.25% from their previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app